AGP Picks
View all

Alternative Medicine Times
Provided by AGP

Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 24, 2026

NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum
Jun. 24, 2026

NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum

Indeterminate GlobeNewswire
Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
Jun. 24, 2026

Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District

Indeterminate GlobeNewswire
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
Jun. 24, 2026

Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market

Indeterminate GlobeNewswire
Bionano Announces Hiring of Chief Scientific Officer
Jun. 24, 2026

Bionano Announces Hiring of Chief Scientific Officer

Indeterminate GlobeNewswire
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases
Jun. 24, 2026

Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases

Indeterminate GlobeNewswire
AMASS Brands Group Enters SAFE Investment in Afterdream, a Fast-Growing Hemp-Derived THC Beverage Brand
Jun. 24, 2026

AMASS Brands Group Enters SAFE Investment in Afterdream, a Fast-Growing Hemp-Derived THC Beverage Brand

Indeterminate GlobeNewswire
The Quest to Repair What Multiple Sclerosis Takes Away
Jun. 24, 2026

The Quest to Repair What Multiple Sclerosis Takes Away

Indeterminate GlobeNewswire
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
Jun. 24, 2026

LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand

Indeterminate GlobeNewswire
AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
Jun. 24, 2026

AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones

Indeterminate GlobeNewswire
BrewDog and Tilray Beer Are Ready to Pour the World’s Biggest Bar Tab — £1 Million of Free Pints
Jun. 24, 2026

BrewDog and Tilray Beer Are Ready to Pour the World’s Biggest Bar Tab — £1 Million of Free Pints

Indeterminate GlobeNewswire
Gaxos.ai Inc. Sells Gaming Assets to Game Foundry AI
Jun. 24, 2026

Gaxos.ai Inc. Sells Gaming Assets to Game Foundry AI

Indeterminate GlobeNewswire
Noom Members Regained 3x Less Weight After Stopping GLP-1s vs Standard-of-Care, New Analyses Show
Jun. 24, 2026

Noom Members Regained 3x Less Weight After Stopping GLP-1s vs Standard-of-Care, New Analyses Show

Indeterminate GlobeNewswire
NOVAGOLD Files Second Quarter 2026 Report Advancing Key Donlin Gold Workstreams Up the Value Chain to Build America’s Largest Gold Mine
Jun. 24, 2026

NOVAGOLD Files Second Quarter 2026 Report Advancing Key Donlin Gold Workstreams Up the Value Chain to Build America’s Largest Gold Mine

Indeterminate GlobeNewswire
Imbria Pharmaceuticals Receives FDA Orphan Drug Designation for Ninerafaxstat for Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Jun. 24, 2026

Imbria Pharmaceuticals Receives FDA Orphan Drug Designation for Ninerafaxstat for Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Indeterminate GlobeNewswire
Homes for Heroes Foundation Surpasses $2 Million in Grants Supporting Heroes Nationwide
Jun. 24, 2026

Homes for Heroes Foundation Surpasses $2 Million in Grants Supporting Heroes Nationwide

Indeterminate GlobeNewswire
Response Biomedical Expands Global Diagnostics Portfolio with the Launch of the RAMP Xpress
Jun. 24, 2026

Response Biomedical Expands Global Diagnostics Portfolio with the Launch of the RAMP Xpress

Indeterminate GlobeNewswire
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
Jun. 24, 2026

Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit

Indeterminate GlobeNewswire
Picard Medical Announces Leadership Transition
Jun. 24, 2026

Picard Medical Announces Leadership Transition

Indeterminate GlobeNewswire
EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
Jun. 24, 2026

EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives

Indeterminate GlobeNewswire
Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress
Jun. 24, 2026

Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Alternative Medicine Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.